tirzepatide compounding news Impurity in Some Compounded 'Potentially Dangerous,' Eli Lilly Warns Compounded Tirzepatide: Legal & Safe

The SURMOUNT-1 trial showed 21.4% body weight reduction at the 10 mg dose, which is remarkable on its own

It can be administered in the thigh, abdomen, or upper arm , depending on patient preference

Unregulated or improperly used GLP-1 drugs can cause anxiety, mood changes, and in some cases, worsen depression or eating disorder symptoms especially in individuals with pre-existing mental health conditions

Send Us A Message Here

Heres what patients at Avellina Aesthetics regularly experience: Significant, Sustained Weight Reduction Clinical studies have demonstrated that patients using semaglutide for chronic weight management lose an average of 1015% of their total body weight over several months with some patients exceeding that range when combining treatment with lifestyle modifications